Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE.
Mei MG, Lee HJ, Palmer JM, Chen R, Tsai NC, Chen L, McBride K, Smith DL, Melgar I, Song JY, Bonjoc KJ, Armenian S, Nwangwu M, Lee PP, Zain J, Nikolaenko L, Popplewell L, Nademanee A, Chaudhry A, Rosen S, Kwak L, Forman SJ, Herrera AF.
Mei MG, et al. Among authors: chen l, chen r.
Blood. 2022 Jun 23;139(25):3605-3616. doi: 10.1182/blood.2022015423.
Blood. 2022.
PMID: 35316328
Free PMC article.
Clinical Trial.